Table 1: Profile of the study population according to demographic, cardiovascular risk, kidney disease characteristics and serum 25-OH vitamin D.
Characteristics | n = 141 |
Demographic | |
Agea | 58.8 ± 16.0 years |
Gender | |
Male | 66 (45.3%) |
Female | 75 (54.7%) |
Race | |
Non-black | 114 (81.0%) |
Black | 27 (19.0%) |
Cardiovascular risk-related factors | |
BMIa | 27.0 ± 5.3 Kg/m2 |
Obesity | 29 (22.0%) |
Inactivity | 104 (78.2%) |
Smoking: smoker or ex-smoker | 48 (35.6%) |
Hypertension | 122 (89.1%) |
DM | 48 (35.3%) |
CAD | 20 (14.7%) |
History of stroke | 20 (14.7%) |
Dyslipidemia | 85 (62.0%) |
Family history of CAD | 15 (11.0%) |
Chronic kidney disease etiology | |
DM | 37 (27.0%) |
Hypertension | 38 (27.7%) |
Glomerulopathy | 27 (19.7%) |
ADPKD | 7 (5.1%) |
CPN | 9 (6.6%) |
Indeterminate | 9 (6.6%) |
Others | 10 (7.3%) |
Chronic kidney disease stage | |
3a | 17 (12.4%) |
3b | 27 (19.7%) |
4 | 68 (49.6%) |
5 | 25 (18.3%) |
Serumvit D (ng/mL)a | 24.31 ± 9.51 |
SerumVit D (ng/mL) classification | |
Insufficient/deficient (< 30) | 109 (79.6%) |
Normal (> 30) | 28 (20.4%) |
aMean ± standard deviation.
Abbreviations: BMI: Body mass index; DM: Diabetes mellitus; CAD: Coronary artery disease; ADPKD: Autosomal dominant polycystic kidney disease; CPN: Chronic pyelonephritis; vit D: 25-OH vitamin D.